These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37354155)
1. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy. Fahmy AS; Rowin EJ; Jaafar N; Chan RH; Rodriguez J; Nakamori S; Ngo LH; Pradella S; Zocchi C; Olivotto I; Manning WJ; Maron M; Nezafat R JACC Cardiovasc Imaging; 2024 Jan; 17(1):16-27. PubMed ID: 37354155 [TBL] [Abstract][Full Text] [Related]
2. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death. Freitas P; Ferreira AM; Arteaga-Fernández E; de Oliveira Antunes M; Mesquita J; Abecasis J; Marques H; Saraiva C; Matos DN; Rodrigues R; Cardim N; Mady C; Rochitte CE J Cardiovasc Magn Reson; 2019 Aug; 21(1):50. PubMed ID: 31412875 [TBL] [Abstract][Full Text] [Related]
3. Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines. Wang J; Yang S; Ma X; Zhao K; Yang K; Yu S; Yin G; Dong Z; Song Y; Cui C; Li J; Wang C; Hao J; Lu M; Chen X; Zhao S Eur Heart J; 2023 Dec; 44(45):4781-4792. PubMed ID: 37795986 [TBL] [Abstract][Full Text] [Related]
4. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy. Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228 [TBL] [Abstract][Full Text] [Related]
5. ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients. Hinojar R; Zamorano JL; Gonzalez Gómez A; Plaza Martin M; Esteban A; Rincón LM; Portugal JC; Jimenez Nácher JJ; Fernández-Golfín C Clin Cardiol; 2017 Oct; 40(10):853-860. PubMed ID: 28614597 [TBL] [Abstract][Full Text] [Related]
6. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy. Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820 [TBL] [Abstract][Full Text] [Related]
7. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy. Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532 [TBL] [Abstract][Full Text] [Related]
8. Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study. Greulich S; Seitz A; Herter D; Günther F; Probst S; Bekeredjian R; Gawaz M; Sechtem U; Mahrholdt H Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):732-741. PubMed ID: 33458753 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. He D; Ye M; Zhang L; Jiang B Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876 [TBL] [Abstract][Full Text] [Related]
11. Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method. Zhao X; Jin F; Wang J; Zhao X; Wang L; Wei H Int J Cardiol; 2023 Feb; 373():134-141. PubMed ID: 36395920 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score. Todiere G; Nugara C; Gentile G; Negri F; Bianco F; Falletta C; Novo G; Di Bella G; De Caterina R; Zachara E; Re F; Clemenza F; Sinagra G; Emdin M; Aquaro GD Am J Cardiol; 2019 Oct; 124(8):1286-1292. PubMed ID: 31447011 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Late Gadolinium Enhancement Cardiac Magnetic Resonance and Sudden Death in Hypertrophic Cardiomyopathy: A Meta-Analysis. Kiaos A; Daskalopoulos GN; Kamperidis V; Ziakas A; Efthimiadis G; Karamitsos TD JACC Cardiovasc Imaging; 2024 May; 17(5):489-497. PubMed ID: 37632503 [TBL] [Abstract][Full Text] [Related]
14. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826 [TBL] [Abstract][Full Text] [Related]
15. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis. Kamp NJ; Chery G; Kosinski AS; Desai MY; Wazni O; Schmidler GS; Patel M; Lopes RD; Morin DP; Al-Khatib SM Prog Cardiovasc Dis; 2021; 66():10-16. PubMed ID: 33171204 [TBL] [Abstract][Full Text] [Related]
16. Radiomics Analysis Derived From LGE-MRI Predict Sudden Cardiac Death in Participants With Hypertrophic Cardiomyopathy. Wang J; Bravo L; Zhang J; Liu W; Wan K; Sun J; Zhu Y; Han Y; Gkoutos GV; Chen Y Front Cardiovasc Med; 2021; 8():766287. PubMed ID: 34957254 [No Abstract] [Full Text] [Related]
17. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. Green JJ; Berger JS; Kramer CM; Salerno M JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326 [TBL] [Abstract][Full Text] [Related]
18. Late Gadolinium Enhancement-Dispersion Mapping: A New Magnetic Resonance Imaging Technique to Assess Prognosis in Patients With Hypertrophic Cardiomyopathy and Low-Intermediate 5-Year Risk of Sudden Death. Aquaro GD; Grigoratos C; Bracco A; Proclemer A; Todiere G; Martini N; Habtemicael YG; Carerj S; Sinagra G; Di Bella G Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010489. PubMed ID: 32539460 [TBL] [Abstract][Full Text] [Related]
19. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy. Zegkos T; Tziomalos G; Parcharidou D; Ntelios D; Papanastasiou CA; Karagiannidis E; Gossios T; Rouskas P; Katranas S; Paraskevaidis S; Karvounis H; Efthimiadis G Hellenic J Cardiol; 2022; 63():15-21. PubMed ID: 34147674 [TBL] [Abstract][Full Text] [Related]
20. High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy. Gommans DHF; Cramer GE; Bakker J; Dieker HJ; Michels M; Fouraux MA; Marcelis CLM; Verheugt FWA; Timmermans J; Brouwer MA; Kofflard MJM Int J Cardiovasc Imaging; 2018 Jan; 34(1):113-120. PubMed ID: 29063221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]